The Sermo Barometer survey which included 507 U.S.-based doctors across cardiology, dermatology, endocrinology, internal medicine, neurology, and orthopedic surgery highlights a concern among physicians: that patient-driven adoption has already outpaced both clinical consensus and regulatory infrastructure
Patients who use unapproved formulations assume risks that are difficult to quantify because the data to assess those risks does not yet exist
Gandhi recommends either Semaglutide or Tirzepatide along with supporting therapies
A licensed healthcare provider reviews your information and determines if semaglutide is appropriate for you
The information above is not a representation of our views at GotProtein
For people who need rapid appetite control or have digestive conditions that impair absorption, the injection provides more reliable results from the first dose